Skip to content

The Role of Pharmacists in Safe Medicine Use: Patient and Healthcare Provider Experiences

Patient Experience and Provider Insights into Pharmacist Led Medication Reconciliation A Mixed Method Study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/099063
Enrollment
275
Registered
2025-12-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: -

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

SRM Collage of Pharmacy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Quantitative Patients 1. Patients aged 18 years and above. 2. Hospitalized in the selected medical wards. 3. Receiving at least one chronic medication (used continuously for more than or equal to 3 months). 4. Planned for discharge during the study period. 5. Patients able to provide informed consent. 6. Patients able to communicate in the local language and understand the questionnaire. Qualitative Component Healthcare Professionals 1. Doctors, nurses, clinical pharmacists, or Intern PharmD students involved in discharge medication processes in the selected wards.(Obstetrics and Gynaecology, Dermatology OR Respiratory Medicine, General medicine) 2. Willing to provide informed consent for participation in interviews or FGDs.

Exclusion criteria

Exclusion criteria: Quantitative Patients 1. Patients discharged against medical advice (DAMA) 2. Patients with Mini-Mental State Exam score less than 24. 3. Patients transferred to other hospitals before discharge 4. Patients with terminal illness or requiring palliative care. 5. Patients unable to participate in follow up or comprehend discharge instructions. Qualitative Component Healthcare Professionals 1. HCPs not involved in discharge or medication related processes 2. Those unwilling to participate or unable to provide consent

Design outcomes

Primary

MeasureTime frame
To identify and resolve medication discrepancies at the time of hospital stay through pharmacist-led medication reconciliation(MedRec) in the key areas of polypharmacy and transition of care. To ensure accurate medication management at the point of hospital discharge through pharmacist-led reconciliation To explore healthcare professionals perspectives on the implementation, challenges, and potential improvements of discharge MedRec using qualitative methods such as interviews or focus group discussions. Timepoint: To identify and resolve medication discrepancies at the time of hospital stay through pharmacist-led medication reconciliation(MedRec) in the key areas of polypharmacy and transition of care. To ensure accurate medication management at the point of hospital discharge through pharmacist-led reconciliation To explore healthcare professionals perspectives on the implementation, challenges, and potential improvements of discharge MedRec using qualitative methods such as interviews or focus group discussions.

Secondary

MeasureTime frame
To assess patient satisfaction & understanding of their discharge medications following the reconciliation process. To categorize the types & frequency of medication discrepancies identified during reconciliation empirically, based on the data collected. Timepoint: duration of hospital stay

Countries

India

Contacts

Public ContactSSPravin

SRM College of Pharmacy

sspravin004@gmail.com7010051101

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026